Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hubbard

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Therapeutic Drug Monitoring|January 1, 1986
Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human bloodE M Hawes, J W Hubbard, M Martin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failureJ Wang, G Zhao, W Shen, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidolK K Midha, B S Chakraborty, R Schwede, et al.
Therapeutic Drug Monitoring|January 1, 1985
Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysisG McKay, J K Cooper, E M Hawes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1991
Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugatesC J Jackson, J W Hubbard, G McKay, et al.
Therapeutic Drug Monitoring|January 1, 1988
An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detectionK K Midha, J K Cooper, E M Hawes, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1991
Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunctionC M Paap, M C Nahata, M A Mentser, et al.
Journal of Clinical Pharmacology|July 1, 1995
The pharmacokinetics and cardiovascular pharmacodynamics of HP 749 (besipirdine HCl) and metabolite P86-7480 in the conscious monkeyJ W Hubbard, R S Hsu, L Griffiths, et al.
The British Journal of Psychiatry. Supplement|December 1, 1993
Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implicationsJ W Hubbard, K K Midha, E M Hawes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1990
The identification of urinary metabolites of doxepin in patientsY Z Shu, J W Hubbard, J K Cooper, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Therapeutic Drug Monitoring|January 1, 1986
Therapeutic monitoring of chlorpromazine. III: Minimal interconversion between chlorpromazine and metabolites in human bloodE M Hawes, J W Hubbard, M Martin, et al.
Journal of Cardiovascular Pharmacology|January 1, 1993
Effects of an orally active NO-releasing agent, CAS 936, and its active metabolite, 3754, on cardiac and coronary dynamics in normal conscious dogs and after pacing-induced heart failureJ Wang, G Zhao, W Shen, et al.
Journal of Pharmaceutical Sciences|June 1, 1989
Comparative bioavailability of a new commercial tablet formulation and two lots of a reference formulation of haloperidolK K Midha, B S Chakraborty, R Schwede, et al.
Therapeutic Drug Monitoring|January 1, 1985
Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysisG McKay, J K Cooper, E M Hawes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1991
Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugatesC J Jackson, J W Hubbard, G McKay, et al.
Therapeutic Drug Monitoring|January 1, 1988
An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detectionK K Midha, J K Cooper, E M Hawes, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1991
Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunctionC M Paap, M C Nahata, M A Mentser, et al.
Journal of Clinical Pharmacology|July 1, 1995
The pharmacokinetics and cardiovascular pharmacodynamics of HP 749 (besipirdine HCl) and metabolite P86-7480 in the conscious monkeyJ W Hubbard, R S Hsu, L Griffiths, et al.
The British Journal of Psychiatry. Supplement|December 1, 1993
Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implicationsJ W Hubbard, K K Midha, E M Hawes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1990
The identification of urinary metabolites of doxepin in patientsY Z Shu, J W Hubbard, J K Cooper, et al.
Pageof 12